BioXcel Therapeutics Inc (BTAI) Insider Trading
- $260,881.51
- $23,980,342.06
- Oct. 3, 2024
- Vimal Mehta
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Oct. 3, 2024 | Insider | 6,272 | $0.55 | Sell | $3,449.60 | |
| Oct. 3, 2024 | CFO | 7,175 | $0.55 | Sell | $3,946.25 | |
| Sept. 16, 2024 | CEO | 1,982 | $0.69 | Sell | $1,367.58 | |
| Sept. 16, 2024 | Insider | 355 | $0.69 | Sell | $244.95 | |
| Sept. 16, 2024 | CFO | 356 | $0.69 | Sell | $245.64 | |
| June 17, 2024 | CEO | 2,134 | $1.28 | Sell | $2,731.52 | |
| June 17, 2024 | Insider | 372 | $1.28 | Sell | $476.16 | |
| June 4, 2024 | CEO | 126,014 | $1.63 | Sell | $205,402.82 | |
| April 4, 2024 | Insider | 165 | $2.62 | Sell | $432.30 | |
| April 4, 2024 | CFO | 1,069 | $2.63 | Sell | $2,811.47 | |
| April 4, 2024 | CEO | 5,268 | $2.62 | Sell | $13,802.16 | |
| June 15, 2023 | CEO | 30,000 | $21.54 | Sell | $646,200.00 | |
| May 22, 2023 | CEO | 6,500 | $25.79 | Sell | $167,635.00 | |
| May 15, 2023 | Insider | 1,785 | $27.32 | Sell | $48,766.20 | |
| May 15, 2023 | CFO | 5,000 | $27.17 | Sell | $135,850.00 | |
| April 6, 2023 | Director | 60,000 | $17.32 | Sell | $1,039,200.00 | |
| March 20, 2023 | CEO | 34,500 | $18.32 | Sell | $632,040.00 | |
| March 15, 2023 | CFO | 2,084 | $19.50 | Sell | $40,638.00 | |
| March 15, 2023 | Insider | 985 | $19.69 | Sell | $19,394.65 | |
| Jan. 20, 2023 | Insider | 50,000 | $30.00 | Sell | $1,500,000.00 | |
| Jan. 5, 2023 | Director | 25,889 | $22.34 | Sell | $578,360.26 | |
| Dec. 16, 2022 | CEO | 30,000 | $19.44 | Sell | $583,200.00 | |
| Nov. 10, 2022 | Director | 27,450 | $15.00 | Sell | $411,750.00 | |
| June 25, 2021 | CEO | 473,250 | $30.83 | Sell | $14,590,297.50 | |
| Feb. 17, 2021 | Insider | 25,000 | $55.58 | Sell | $1,389,500.00 | |
| Jan. 25, 2021 | Insider | 15,000 | $48.39 | Sell | $725,850.00 | |
| Jan. 19, 2021 | Insider | 25,000 | $49.47 | Sell | $1,236,750.00 | |
| Aug. 22, 2019 | Director | 8,446 | $8.74 | Buy | $73,818.04 | |
| Aug. 15, 2019 | CEO | 2,983 | $8.64 | Buy | $25,773.12 | |
| Aug. 13, 2019 | Insider | 6,547 | $8.67 | Buy | $56,762.49 | |
| Aug. 13, 2019 | CEO | 1,000 | $8.75 | Buy | $8,750.00 | |
| Dec. 14, 2018 | CEO | 2,000 | $4.38 | Buy | $8,760.00 | |
| Dec. 7, 2018 | Director | 8,795 | $5.01 | Buy | $44,062.95 | |
| Dec. 4, 2018 | Director | 4,007 | $5.13 | Buy | $20,555.91 | |
| Dec. 4, 2018 | Insider | 900 | $5.21 | Buy | $4,689.00 | |
| Dec. 3, 2018 | CEO | 1,000 | $5.17 | Buy | $5,170.00 | |
| Dec. 3, 2018 | CFO | 500 | $5.20 | Buy | $2,600.00 | |
| Nov. 30, 2018 | CEO | 1,000 | $5.10 | Buy | $5,100.00 | |
| Nov. 30, 2018 | Insider | 450 | $5.20 | Buy | $2,340.00 | |
| Nov. 29, 2018 | CFO | 500 | $5.00 | Buy | $2,500.00 |
Insiders are both buying and selling BioXcel Therapeutics Inc stock.
The insider traders at BioXcel Therapeutics Inc are: Vimal Mehta, Frank Yocca, Richard I Steinhart, Vincent O'neill, Krishnan Nandabalan, Peter Mueller, Matthew T Wiley, and Javier Rodriguez
The most active insider trader at BioXcel Therapeutics Inc is Vimal Mehta with 14 trades.
Vimal Mehta has sold the most BioXcel Therapeutics Inc stock with a total value of $16,844,044.16.
Peter Mueller has bought the most BioXcel Therapeutics Inc stock with a total value of $212,254.94.
The most recent insider trade for BioXcel Therapeutics Inc was on Oct. 3, 2024.
The single biggest insider buy for BioXcel Therapeutics Inc was from Peter Mueller with a total value of $73,818.04 on Aug. 22, 2019.
The single biggest insider sell for BioXcel Therapeutics Inc was from Vimal Mehta with a total value of $14,590,297.50 on June 25, 2021.